A phase III study to investigate the effect of daily ingestion of four then two Kivia (Trademark) 575mg Zyactinase (Registered Trademark) or placebo capsules on stool frequency and abdominal pain severity when given to subjects with constipation dominant Irritable Bowel Syndrome
/ CompletedNot Applicable Effects of Kivia powder on gut health in patients with occasional constipation: a randomized double-blind, placebo-controlled study
100 Clinical Results associated with Vital Food Processors Ltd.
0 Patents (Medical) associated with Vital Food Processors Ltd.
100 Deals associated with Vital Food Processors Ltd.
100 Translational Medicine associated with Vital Food Processors Ltd.